Shares of Swiss drugmaker Novartis climbed as much as 4.8% in early deals Tuesday after it raised its full-year guidance following better-than-expected first-quarter results. Read this story
Shares of Swiss drugmaker Novartis climbed as much as 4.8% in early deals Tuesday after it raised its full-year guidance following better-than-expected first-quarter results. Read this story
More from CNBC | Novartis AG Earnings Health care industry Pharmaceuticals Biotechnology Biotech and Pharmaceuticals Business business news cnbc Articles Business News Health & Science Europe News US: News source:tagname:CNBC Europe Source